Desloratadine therapy for symptoms associated with perennial allergic rhinitis

Annals of Allergy, Asthma and Immunology

Volumn 96, Issue 3, 2006, Pages 460-465

  Kim, Kenneth ^a   Sussman, Gordon ^b   Hébert, Jacques ^c   Lumry, William ^d   Lutsky, Barry ^e   Gates, Davis ^e  

^a West Coast Clinical Trials LLC   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c Centre de Recherche Appliqué en Allergie de Québec   (Canada)

^d AARA Research Center   (United States)

^e MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESLORATADINE; HISTAMINE H1 RECEPTOR ANTAGONIST; PLACEBO;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; FEMALE; GENERAL CONDITION IMPROVEMENT; HEADACHE; HEART ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; PERENNIAL RHINITIS; PHARYNGITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SYMPTOM; UNITED STATES; UPPER RESPIRATORY TRACT INFECTION;

EID: 33645218722     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60914-3     Document Type: Article

References (16)

1. Fineman SM. The burden of allergic rhinitis: beyond dollars and cents. Ann Allergy Asthma Immunol. 2002;88(suppl 1):2-7.
2. Crystal-Peters J, Crown WH, Goetzel RZ, Schutt DC. The cost of productivity losses associated with allergic rhinitis. Am J Manag Care. 2000;6:373-378.
3. Sibbald B, Rink E. Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history. Thorax. 1991; 46:895-901.
4. Van Cauwenberg P, Bachert C, Passalacqua G, et al. Consensus statement on the treatment of allergic rhinitis: European Academy of Allergology and Clinical Immunology. Allergy. 2000; 55:116-134.
5. Dykewicz MS, Fineman S, Skoner DP, et al. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol. 1998;81(pt 2):478-518.
6. Diemer F, Sanico A, Togias A. Perennial allergic rhinitis (PAR): more severe than seasonal? J Allergy Clin Immunol. 2003;111:8122.
7. Scadding GK, Richards DH, Price MJ. Patient and physician perspectives on the impact and management of perennial and seasonal allergic rhinitis. Clin Otolaryngol Allied Sci. 2000;25: 551-557.
8. Bertrand B, Jamart J, Marchal JL, Arendt C. Cetirizine and pseudoephedrine retard alone and in combination in the treatment of perennial allergic rhinitis: a double-blind multicentre study. Rhinology. 1996;34:91-96.
9. Bousquet J, Gaudano EM, Palma Carlos AG, Staudinger H; Multicentre Study Group. A 12-week, placebo-controlled study of the efficacy and safety of ebastine, 10 and 20 mg once daily, in the treatment of perennial allergic rhinitis. Allergy. 1999;54: 562-568.
10. 1-receptor antagonist, in patients with seasonal allergic rhinitis: assessment during the spring and fall allergy seasons. Clin Drug Invest. 2001;21:25-32.
11. Salmun L, Lorber R. 24-Hour efficacy of once-daily desloratadine therapy in patients with seasonal allergic rhinitis [IS-RCTN32042139]. BMC Fam Pract. 2002;3:14.
12. Bachert C. Decongestant efficacy of desloratadine in patients with seasonal allergic rhinitis. Allergy. 2001;56(suppl 65): 14-20.
13. Nayak AS, Schenkel E. Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis. Allergy. 2001;56: 1077-1080.
14. Horak F, Stubner P. Decongestant activity of desloratadine in controlled-allergen-exposure trials. Clin Drug Invest. 2002; 22(suppl 2):13-20.
15. Simons FER, Prenner BM, Finn A Jr; Desloratadine Study Group. Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis. J Allergy Clin Immunol. 2003;111: 617-622.
16. Wilson A, Dempsey OJ, Sims EJ, et al. Evaluation of treatment response in patients with seasonal allergic rhinitis using domiciliary nasal peak inspiratory flow. Clin Exp Allergy. 2000;30:833-838.